Pertussis historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}
{{CMG}} {{AE}} {{LRO}}
{{Pertussis}}
{{Pertussis}}



Revision as of 17:34, 5 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Pertussis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pertussis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pertussis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pertussis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pertussis historical perspective

CDC onPertussis historical perspective

Pertussis historical perspective in the news

Blogs on Pertussis historical perspective

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pertussis historical perspective

Overview

Pertussis was recognizably described as early as 1578 by Guillaume de Baillou (1538-1616), but earlier reports date back at least to the 12th century.[1] B. pertussis was isolated in pure culture in 1906 by Jules Bordet and Octave Gengou, who also developed the first serology and vaccine. The complete B. pertussis genome of 4,086,186 base pairs was sequenced in 2002.

Historical Perspective

Discovery

  • The earliest evidence of people displaying symptoms of Pertussis occurred during the Middle Ages, described as "the kink" or "the kindhoest" in Scotland to indicate a cough or fit.[2]
  • The first offically recognized outbreak of Pertussis was in 1502 in the former Persian Empire, recorded by Persian Physician Bahaodowle Razi.[3]
  • Pertussis was first officially recognized in Europe by French physician Guillaume de Baillou in 1578 during its outbreak in Paris.[2].
  • The causative organism, Bordetella pertussis, was discovered and isolated in 1906 by Belgian biologists Jules Bordet and Octave Gengou.

Development of Treatment Strategies

  • Jules Bordet and Octave Gengou developed the first vaccine and serological test for Pertussis following discovery of Bordetella pertussis.
  • In 1942, American scientists Grace Eldering, Loney Gordon, and Pearl Kendrick combined the whole-cell pertussis vaccine with diphtheria and tetanus toxoids to generate the first DTP combination vaccine.
  • In 1981 an acelluar vaccine was created in Japan and was added, in 1992, to the DTP Vaccine to create the DTaP vaccine, which had a much smaller rate of adverse side effects.[4]

References

  1. Versteegh FGA, Schellekens JFP, Fleer A, Roord JJ. (2005). "Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management". Rev Med Microbiol. 16 (3): 79–89.
  2. 2.0 2.1 Cherry, James D. (November 1996). "Historical Review of Pertussis and the Classical Vaccine" (PDF). Journal of Infectious Diseases. Oxford. 174 (3): 259–263. Retrieved 5 January 2016.
  3. Yarmohammadi H, Bahmani Kazeruni MH, Soofi A, Zargaran A (2015). "The First Report of Epidemic Pertussis by Bahaodowle Razi From the 15th Century Anno Domini". Iran Red Crescent Med J. 17 (7): e13454. doi:10.5812/ircmj.13454. PMC 4580069. PMID 26413316.
  4. Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M; et al. (2005). "Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults". JAMA. 293 (24): 3003–11. doi:10.1001/jama.293.24.3003. PMID 15933223. Review in: Evid Based Med. 2006 Apr;11(2):51

Template:WH Template:WS